Zimmer Biomet has received the US Food and Drug Administration (FDA) 510(k) clearance for the use of its JuggerStitch device in meniscal repair procedures.
Conventional knotted meniscal repair devices come with hard plastic anchors and its surface knots can damage cartilage. These devices are associated with more risk of complications.
Zimmer Biomet’s meniscal repair device offers a less invasive, all-suture, knotless alternative for better patient treatment outcomes.
JuggerStitch implant has two soft anchors that are linked by a knotless, self-locking suture loop.
The company added that the device is meant for improved tissue preservation and control of the tissue compression at the repair site, compared to implants requiring sliding knot to lock the repair.
Zimmer Biomet meniscal repair range, which also includes CrossFix and MaxFire MarXmen devices, is part of its sports medicine portfolio.
The portfolio also comprises products for repairs of the rotator cuff, shoulder labral and biceps and AC joint, among others.
Zimmer Biomet chief medical officer Dr Andrew Freiberg said: “Zimmer Biomet is committed to delivering cutting-edge technology and solutions, like the next-generation JuggerStitch meniscal repair device, to help surgeons alleviate pain, restore peak performance and improve the quality of life for patients.
“Our comprehensive sports medicine portfolio provides a variety of options that help patients throughout the care continuum.”
Founded in 1927, the company focuses on musculoskeletal healthcare. It develops products and solutions for disorders or injuries of bones and joints, as well as supporting soft tissues.
In March, Zimmer Biomet secured FDA clearance for its ROSA ONE Spine System in robotically assisted surgeries. The spine system integrates a real-time patient tracking capability and 3D intra-operative planning software for improved placement of implants.